Bioverativ Inc (BIVV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIVV | JAZZ | EXEL | ||
| Company | Bioverativ Inc | Jazz Pharma Plc | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 104.97 | 187.01 | 41.25 | ||
| High | 105.01 | 189.02 | 41.35 | ||
| Low | 104.97 | 185.44 | 40.54 | ||
| Latest | 104.98 | 185.57 | 40.60 | ||
| Change | +0.33 | -3.12 | -1.09 | ||
| % Change | +0.32% | -1.65% | -2.61% | ||
| Volume | 792,900 | 234,112 | 442,961 | ||
| 20-Day Average Volume | 2,587,600 | 1,063,729 | 3,077,926 | ||
| Previous Close | 104.65 | 188.69 | 41.69 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 104.18 | 175.59 | 43.28 | ||
| 20-Day Raw Stochastic | 98.80% | 68.49% | 16.07% | ||
| 20-Day Relative Strength | 86.97 | 62.17 | 40.80 | ||
| Weighted Alpha | +58.00 | +45.01 | -0.43 | ||
| Today's Opinion | N/A | 100% Buy | 8% Sell | ||
| Previous Opinion | N/A | 100% Buy | 24% Buy | ||
| Last Month's Opinion | N/A | 56% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.30% since 03/01/18 | -1.33% since 02/26/26 | -8.08% since 02/26/26 | ||
| Low | 104.14 on 03/06/18 | 184.15 on 03/04/26 | 39.71 on 03/02/26 | ||
| High | 105.01 on 03/08/18 | 192.70 on 02/27/26 | 44.88 on 02/27/26 | ||
| 1-Month | |||||
| %Chg | +1.78% since 02/08/18 | +14.29% since 02/05/26 | -3.94% since 02/05/26 | ||
| Low | 102.51 on 02/09/18 | 161.38 on 02/11/26 | 39.71 on 03/02/26 | ||
| High | 105.01 on 03/08/18 | 198.00 on 02/26/26 | 45.87 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | +103.96% since 12/08/17 | +9.88% since 12/05/25 | -8.25% since 12/05/25 | ||
| Low | 51.25 on 12/11/17 | 156.95 on 01/08/26 | 39.71 on 03/02/26 | ||
| High | 105.01 on 03/08/18 | 198.00 on 02/26/26 | 47.24 on 12/23/25 | ||
| 6-Month | |||||
| %Chg | +83.92% since 09/08/17 | +43.98% since 09/05/25 | +7.44% since 09/05/25 | ||
| Low | 48.28 on 12/01/17 | 123.88 on 09/15/25 | 33.76 on 10/20/25 | ||
| High | 105.01 on 03/08/18 | 198.00 on 02/26/26 | 47.24 on 12/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,360,936 | 11,615,756 | 10,827,269 | ||
| Shares Outstanding, K | 108,220 | 61,560 | 259,709 | ||
| Annual Sales | 1,168,500,000 | 4,267,590,000 | 2,320,130,000 | ||
| Annual Net Income | 355,600,000 | -356,150,000 | 782,570,000 | ||
| Last Quarter Sales | 328,700,000 | 1,197,930,000 | 598,660,000 | ||
| Last Quarter Net Income | 96,300,000 | 203,450,000 | 244,530,000 | ||
| 60-Month Beta | N/A | 0.22 | 0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.95 on 02/13/18 | 6.64 on 02/24/26 | 0.94 on 02/10/26 | ||
| Latest Earnings Date | 05/02/18 | 05/05/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 38.05 | 43.61 | 14.92 | ||